简介：
Overview
This protocol outlines the isolation of clinical-grade antigen-specific T cells for adoptive immunotherapy using a cytokine capture system. The method allows for the direct administration of cytomegalovirus (CMV) pp65-specific T cells to patients without the need for a GMP facility.
Key Study Components
Area of Science
- Immunotherapy
- Cell Enrichment Techniques
- Pathogen-Specific T Cell Production
Background
- Adoptive immunotherapy utilizes T cells to target specific pathogens.
- Cytomegalovirus (CMV) is a significant target in immunotherapy.
- Traditional methods require extensive resources and facilities.
- This protocol introduces an automated system for T cell isolation.
Purpose of Study
- To manufacture pathogen-specific clinical-grade T cells.
- To simplify the process of T cell isolation for clinical use.
- To enhance the efficiency of T cell production without GMP constraints.
Methods Used
- Incubation of mononuclear cells with overlapping peptides from CMV pp65.
- Activation of T cells to express IFN gamma.
- Isolation of CD45 positive IFN gamma expressing T cells via cytokine capture.
- Assessment of T cell number and purity using flow cytometry.
Main Results
- High percentage of CD4 and CD8 positive CMV specific T cells can be harvested.
- The automated system improves efficiency and reduces resource needs.
- Clinical-grade T cells can be produced without GMP facilities.
Conclusions
- This method provides a viable alternative for T cell production in clinical settings.
- Automation enhances the reproducibility and accessibility of T cell therapies.
- The approach may facilitate broader applications in adoptive immunotherapy.
What is the main advantage of this T cell isolation method?
The main advantage is that it is fully automated and does not require a GMP facility.
How are the T cells activated in this protocol?
T cells are activated by incubating mononuclear cells with overlapping peptides derived from CMV pp65.
What type of T cells are produced using this method?
The method produces CMV pp65-specific CD4 and CD8 positive T cells expressing IFN gamma.
How is the purity of the isolated T cells assessed?
Purity is assessed using flow cytometry.
Can this method be used for other pathogens?
While this protocol is specific to CMV, similar methods could potentially be adapted for other pathogens.
What is the significance of using clinical-grade T cells?
Clinical-grade T cells are essential for safe and effective therapeutic applications in patients.
繁體中文
